SOA Wealth Advisors’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75 Hold
8
﹤0.01% 871
2026
Q1
$65 Hold
8
﹤0.01% 845
2025
Q4
$54 Hold
8
﹤0.01% 849
2025
Q3
$69 Hold
8
﹤0.01% 866
2025
Q2
$50 Hold
8
﹤0.01% 861
2025
Q1
$51 Hold
8
﹤0.01% 865
2024
Q4
$64 Hold
8
﹤0.01% 853
2024
Q3
$101 Hold
8
﹤0.01% 809
2024
Q2
$101 Hold
8
﹤0.01% 820
2024
Q1
$38 Hold
8
﹤0.01% 900
2023
Q4
$38 Buy
+8
New +$49 ﹤0.01% 896
2022
Q4
Sell
-22
Closed 1001
2022
Q3
$0 Hold
22
﹤0.01% 934
2022
Q2
$1K Buy
+22
New +$1.14K ﹤0.01% 771

Other funds holding NVAX

SOA Wealth Advisors's NVAX Position: Q2 2026 in Review

SOA Wealth Advisors held its Novavax (NVAX) position steady in Q2 2026 at 8 shares worth $75. The position accounts for ﹤0.01% of the portfolio, ranked #871.

SOA Wealth Advisors first reported a position in NVAX in Q2 2022 and has held it in 13 quarters since. The position peaked at $1K in Q2 2022. 266 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • SOA Wealth Advisors held 8 shares of Novavax worth $75 as of Q2 2026.
  • SOA Wealth Advisors left its Novavax share count unchanged in Q2 2026.
  • Novavax made up ﹤0.01% of SOA Wealth Advisors's portfolio in Q2 2026, its #871 holding.
  • SOA Wealth Advisors first reported a position in Novavax in Q2 2022 and has held it in 13 quarters since.
  • SOA Wealth Advisors's Novavax position peaked at $1K in Q2 2022.
  • 266 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on SOA Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.